If you spend a decent amount of time following the markets (and the financial media), it can sometimes feel like trying to drink from a firehose.

That’s the price of admission in the Information Age.

But what do we make of all this information? How do we keep our focus on opportunities to profit? To get some perspective, I turned to my colleague, Jimmy Butts.

Jimmy and I have worked together for years, often side by side. As the Chief Investment Strategist of Capital Wealth Letter, Jimmy makes it his mission to deliver insightful analysis and picks with huge upside potential every month.

Below, Jimmy and I talk a little more about the prospects for a recession, what we should do with the Wall Street information barrage, and one huge opportunity he’s particularly excited about right now (hint: it has to do with Hollywood’s latest diet fad).

My questions are in bold.

---

Let’s cut right to the chase. Is there going to be a recession or not?

Right now (more so than usual), nobody has a clue what’s going on. Making matters worse, the guesses that the higher-ups are throwing out there are terrifying.

For example, the International Monetary Fund (IMF) released its new World Economic Outlook report this week. The headline? “A Rocky Recovery.” The organization predicts just 2.8% global growth this year and warned of a hard landing for the global economy.

Then you have Wells Fargo’s head of equity strategy predicting a 10% correction in the S&P 500 within the next 3 to 6 months. He sees the index revisiting the November lows (roughly 3,700) on worsening economic conditions, increased reliance on consumer credit, and potential capital/liquidity issues stemming from the recent banking crisis.

And finally, as we head into earnings season, analysts expect a 6.8% drop (year-over-year) in Q1 profits for S&P 500 companies. They also expect annual revenue growth of just 1.8% for the quarter. The former would be the largest decline since Q2 2020, while the latter would mark the slowest growth since Q3 2020.

What should investors do with all this noise?

Have you seen the Spiderman meme? It’s the one where three Spidermen are all pointing their fingers at each other.

In this case, we have the Fed is pointing one hand at inflation and the other hand at the recent banking crisis. Banks are pointing their fingers at the Fed for raising interest rates too high, too fast. And Wall Street points its fingers at whoever is the best culprit for the week (i.e., the Fed, interest rates, banks, jobs report, whatever important economic figure is coming out).

They are all pointing their fingers at someone or something else.

This leaves us mere peasants confused. One week the culprit is inflation. The next week it is a looming banking crisis. High mortgage rates weighing on the housing sector. The jobs report. Quantitative tightening/easing. War in Ukraine. Tensions with China. The list is longer than a CVS receipt.

And all we want to know is what moves we need to make to protect ourselves, our bank accounts, and our investments. It’s no easy task. Although, it never has been.

I realize my tone is pessimistic. But here’s the thing… it’s all just “noise.” It’s difficult (insane, really) to make investment decisions based on all these opinions. Do we ignore them? No. It’s good to know what’s going on and what people think. After all, human behavior — driven by thoughts and emotions — is what really drives the market.

But if we try to dissect all this, we won’t make a dime in the markets. Why? Because we will be too busy trying to figure out what’s going on instead of investing. I believe they call it paralysis by analysis.

That’s a great point, so let’s switch gears and talk about something that could make investors a lot of money. You recently talked about the fight to combat one of our country’s most significant epidemics… obesity. What’s going on?

I’ve touched on this numerous times over the years. And unfortunately, it’s not going away anytime soon.

I don’t how else to say this… but we have gotten fatter as a nation over the past several decades.

Data from the U.S. Department of Agriculture suggest that the average daily intake in the U.S. in 1970 was around 2,100 calories. By the early 2000s, per-capita consumption had reached nearly 2,600 calories daily. It doesn’t help that processed foods and sugar intake have also surged.

Americans have been consuming more calories. Meanwhile, we are less active. The shift toward lower-activity jobs and increased sitting time is a large factor.

A person is typically considered obese if his or her body mass index (“BMI”) is more than 30. BMI is a simple calculation using height and weight. It is far from perfect… But the BMI gives us a benchmark to compare over time. And the trend is undeniable. Adult obesity in the U.S. (the percentage of adults with a BMI of 30 or greater) has more than tripled since the 1960s.

In the early 1960s, roughly 13% of people were considered obese. The most recent data — released in June 2021 — showed 42%.

We are quickly closing in on nearly one-half of American adults being obese. This is a public health crisis… And it’s going global.

According to the World Health Organization, the worldwide prevalence of obesity has tripled since 1975. Now, more than 650 million adults worldwide live with obesity — around 13% of the global adult population.

So we know obesity can lead to diabetes. And that’s the real “hidden epidemic”. How is Big Pharma responding?

Most people know that you treat diabetes with insulin. But most people don’t know the incredible story of how it was discovered. I won’t recap it here, but it’s worth going back and reading.

The point is, insulin was a true-life saver — and it still is today for millions of people. Now, insulin prices are a hot-button topic for politicians these days… Of course, politicians being politicians, they don’t ever tell the whole story (or the truth).

They’re also fighting yesterday’s battle, as usual. You see, there are two main types of synthetic insulin: human insulin and modern insulin.

Human insulin is made in the lab, with a chemical structure is nearly identical what we produce naturally in the pancreas. Modern insulin has a slightly different structure, and is longer lasting and fast-acting.

Human insulin is already cheap… even free for some people. Heck, it’s been available at Walmart for about $25 per vial for the past 15 years, for example. (People with diabetes typically require between one and six vials per month.) I could go on, but you get the idea.

Modern insulin, on the other hand, is more expensive… as it should be. That incentivizes companies to invest billions of dollars in research and development (“R&D”) to develop modern insulin and other drugs. That’s where a new class of drugs known as GLP-1 agonists comes in.

You referred to these as “miracle weight loss” drugs. Can you explain what’s behind all the hype?

GLP-1 agonists are a group of drugs that helps folks with Type 2 diabetes improve blood sugar control and help with weight loss.

It’s not insulin, but it does help regulate blood sugar by promoting insulin secretion from the pancreas when blood sugar levels are high. More and more often, doctors are turning to these drugs to help manage early and mid-stage Type 2 diabetes. They’re safe and effective at controlling blood sugar levels. Plus, a welcome side effect of these drugs is weight loss.

The problem is getting it into the hands of people who really need it. There’s been a massive shortage. Not because of rising rates of diabetes. Instead, it’s because of its weight loss benefits… becoming Hollywood’s favorite (and not so secret) expensive new diet.

A number of other famous people have admitted to using the drug to quickly shed pounds. And here’s the thing… it works! In fact, several drug companies are already at work on getting approval from the FDA to use these drugs specifically for obesity and weight loss. Not only that, but they’re working on what would essentially be the next generation of these drugs that would be even more effective.

This is a huge game-changer.

Investors would be wise to pay attention to this space. We’re talking about a multi-billion dollar opportunity here.

In the meantime, if you’re looking for game-changing investment ideas with serious upside, then you should check out my investment predictions for 2023…

This report is full of research that challenges the conventional wisdom. And while we don’t have a crystal ball, many of our past predictions have come true, allowing investors the chance to rake in gains of 622%, 823%, and even 1,168%.

From the U.S. dollar to driverless trucks to breakthrough cancer treatments and more… If you’re looking for some “home-run” ideas for your portfolio, then I can’t think of a better place to start.

Go here to learn more.